Our hypothesis that Msx2 is a good prognostic marker in breast cancer was further supported by the subsequent in vitro investigations, when we overexpressed Msx2 in both an immortalized mammary epithelial cell line (MCF10a) and an invasive breast cancer cell line (MDA-MB-231). This evidence concerns the gene MSX2 and breast cancer.